Integration of Genomic and Transcriptomic Markers Improves the Prognosis Prediction of Acute Promyelocytic Leukemia.
Xiaojing LinNiu QiaoYang ShenHai FangQing XueBowen CuiLi ChenHongming ZhuSujiang ZhangYu ChenLu JiangShengyue WangJunmin LiBingshun WangBing ChenZhu ChenSaijuan ChenPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
We have proposed a two-category system for improving prognosis in patients with APL. Molecular markers identified in this study may also provide genomic insights into the disease mechanism for improved therapy.